Platelet Glutamate and Aspartate Uptake in Huntington's Disease

Abstract A possible involvement of amino acid uptake mechanisms in the etiology of the human neurodegenerative disease, Huntington's disease (HD), was investigated. Measurement of glutamate (Glu) and aspartate (Asp) uptake was performed in blood platelets, which have previously been shown to constitute a peripheral model system for central amino acid uptake processes. Analyses of Glu and Asp accumulation at 10−7 M and kinetic examination of the high affinity site for Glu indicate no significant differences between control and HD platelets. A genetically determined defect in amino acid uptake therefore does not seem to underlie the nerve cell loss observed in HD patients.

[1]  R. Schwarcz,et al.  The Human Platelet as a Model for the Glutamatergic Neuron: Platelet Uptake of L‐Glutamate , 1981, Journal of neurochemistry.

[2]  A. Wieraszko.  Stimulation-dependent uptake of glutamic acid by hippocampal slices , 1981, Brain Research.

[3]  R. Schwarcz,et al.  Glutamate-induced neuronal degeneration: studies on the role of glutamate re-uptake. , 1981, Advances in biochemical psychopharmacology.

[4]  P. May,et al.  L-Glutamate toxicity in Huntington's disease fibroblasts. , 1980, Biochemical and biophysical research communications.

[5]  J. Coyle,et al.  Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum , 1979, Journal of neuroscience research.

[6]  J. L. Johnson.  The excitant amino acids glutamic and aspartic acid as transmitter candidates in the vertebrate central nervous system , 1978, Progress in Neurobiology.

[7]  I. Divac.  POSSIBLE PATHOGENESIS OF HUNTINGTON'S CHOREA AND A NEW APPROACH TO TREATMENT , 1977, Acta neurologica Scandinavica.

[8]  R. Hassler,et al.  Effect of frontal cortex ablation on striatal glutamic acid level in rat , 1977, Brain Research.

[9]  S. Stahl.  The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. , 1977, Archives of general psychiatry.

[10]  P. Campochiaro,et al.  Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model. , 1977, Progress in neuro-psychopharmacology.

[11]  P. Mcgeer,et al.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids , 1976, Nature.

[12]  J. Coyle,et al.  Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea , 1976, Nature.

[13]  J. Coyle,et al.  Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. , 1976, Nature.

[14]  P. Roberts,et al.  Structural requirements for the inhibition for L-glutamate uptake by glia and nerve endings , 1975, Brain Research.

[15]  S. H. Snyder,et al.  AMINO ACIDS AS CENTRAL NERVOUS TRANSMITTERS: THE INFLUENCE OF IONS, AMINO ACID ANALOGUES, AND ONTOGENY ON TRANSPORT SYSTEMS for l‐GLUTAMIC AND l‐ASPARTIC ACIDS AND GLYCINE INTO CENTRAL NERVOUS SYNAPTOSOMES OF THE RAT 1 , 1973, Journal of neurochemistry.

[16]  K. Pollak,et al.  Amino acids as central nervous transmitters: the influence of ions, amino acid analogues, and ontogeny on transport systems for L-glutamic and L-aspartic acids and glycine into central nervous synaptosomes of the rat. , 1973, Journal of neurochemistry.

[17]  D. Lucas,et al.  The toxic effect of sodium L-glutamate on the inner layers of the retina. , 1957, A.M.A. archives of ophthalmology.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.